Medical Food Firm Stands Its Ground After FDA Repeats Recall Request
This article was originally published in The Rose Sheet
Executive Summary
Primus Pharmaceuticals say an insert in packages of its Limbrel capsules prescribed to manage metabolic processes associated with osteoarthritis advises that the ingredient baicalin could cause the lung condition acute hypersensitive pneumonitis and elevated liver enzymes in users with allergies to the flavonoid.